Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (808)	12/28/1997 4:20:00 PM
From: Cisco	Respond to of 1894

Frank, There is still plenty of time to get the advertisements ready. The in-fight experiment hasn't occured yet! It has only been proposed at this point. BTW, while we are on the subject of what effect microgravity has on the activities of antimicrobial agents, did I tell you that one of the professiors from my alma mater flew the first U.S. Microgravity Laboratory mission on the shuttle Columbia? He graduated two years ahead of me and was assistant professor by the time I left. Currently he is a Professor of Optometry and Director of the Center for Macromolecular Crystallography at University of Alabama, Birmingaham. In 1995 he formed Diversified Scientific, Inc. (DSI). See if you can pick him out of this picture on Columbia: images.jsc.nasa.gov In case you couldn't tell this is Dr. Larry DeLucas: images.jsc.nasa.gov Cisco P.S. DSI has assembled a team of scientists and engineers with a diversity of experience with emphasis in biomedical sciences, software engineering, and optics with the primary target being integrated approaches to machine vision & imaging for the biomedical sciences. Maybe AccuMed will acquire them next.<g>